Matches in Wikidata for { <http://www.wikidata.org/entity/Q37731967> ?p ?o ?g. }
- Q37731967 description "article científic" @default.
- Q37731967 description "article scientifique" @default.
- Q37731967 description "articolo scientifico" @default.
- Q37731967 description "artigo científico" @default.
- Q37731967 description "artículu científicu espublizáu en 2017" @default.
- Q37731967 description "bilimsel makale" @default.
- Q37731967 description "scientific article published on 08 March 2017" @default.
- Q37731967 description "vedecký článok" @default.
- Q37731967 description "vetenskaplig artikel" @default.
- Q37731967 description "videnskabelig artikel" @default.
- Q37731967 description "vědecký článek" @default.
- Q37731967 description "wetenschappelijk artikel" @default.
- Q37731967 description "wissenschaftlicher Artikel" @default.
- Q37731967 description "наукова стаття, опублікована в березні 2017" @default.
- Q37731967 description "научни чланак" @default.
- Q37731967 description "مقالة علمية نشرت في 08 مارس 2017" @default.
- Q37731967 name "A feasibility study of bevacizumab and vinorelbine in patients with previously treated advanced non-squamous non-small-cell lung cancer" @default.
- Q37731967 name "A feasibility study of bevacizumab and vinorelbine in patients with previously treated advanced non-squamous non-small-cell lung cancer" @default.
- Q37731967 name "A feasibility study of bevacizumab and vinorelbine in patients with previously treated advanced non-squamous non-small-cell lung cancer." @default.
- Q37731967 type Item @default.
- Q37731967 label "A feasibility study of bevacizumab and vinorelbine in patients with previously treated advanced non-squamous non-small-cell lung cancer" @default.
- Q37731967 label "A feasibility study of bevacizumab and vinorelbine in patients with previously treated advanced non-squamous non-small-cell lung cancer" @default.
- Q37731967 label "A feasibility study of bevacizumab and vinorelbine in patients with previously treated advanced non-squamous non-small-cell lung cancer." @default.
- Q37731967 prefLabel "A feasibility study of bevacizumab and vinorelbine in patients with previously treated advanced non-squamous non-small-cell lung cancer" @default.
- Q37731967 prefLabel "A feasibility study of bevacizumab and vinorelbine in patients with previously treated advanced non-squamous non-small-cell lung cancer" @default.
- Q37731967 prefLabel "A feasibility study of bevacizumab and vinorelbine in patients with previously treated advanced non-squamous non-small-cell lung cancer." @default.
- Q37731967 P1433 Q37731967-0A5D1FCD-B6DD-4E65-9418-62B90098A7B5 @default.
- Q37731967 P1476 Q37731967-1E8A89F5-2DEC-44B7-B288-249D98B69EBA @default.
- Q37731967 P2093 Q37731967-6C2FD78E-6FB6-4504-89C8-ADDBD2F03142 @default.
- Q37731967 P2093 Q37731967-6DE69B8C-3C90-4B3E-85BD-5A9B7A1AFCB8 @default.
- Q37731967 P2093 Q37731967-830CC1AC-9C1B-47E5-953F-7CCC7221ECAE @default.
- Q37731967 P2093 Q37731967-98872909-5A1C-4331-AB47-ECBDBBA20A04 @default.
- Q37731967 P2093 Q37731967-B20D2EE9-4EE5-4B5D-9F5A-2F18851287E6 @default.
- Q37731967 P2093 Q37731967-EB6D059E-7F13-46C4-BA9A-111CE5F1B646 @default.
- Q37731967 P2860 Q37731967-07615C2C-6A6F-45F3-B7D0-34C6B5599CCD @default.
- Q37731967 P2860 Q37731967-189DB6E4-F404-4ECE-971A-862FC60D38F8 @default.
- Q37731967 P2860 Q37731967-1DFECA5E-9C42-458C-ACE2-E65BBB258957 @default.
- Q37731967 P2860 Q37731967-37E5CECD-2ED3-4357-962A-CAF91E92F287 @default.
- Q37731967 P2860 Q37731967-4179F035-6CF2-496D-8E8A-9C8962FE0D87 @default.
- Q37731967 P2860 Q37731967-4FBA715C-1624-432B-AE7B-1A4ACDD60639 @default.
- Q37731967 P2860 Q37731967-5227CA4C-FD26-4256-87F0-F26F475A5C90 @default.
- Q37731967 P2860 Q37731967-5FB8101E-4D6A-4250-A855-D16EEB74EAC9 @default.
- Q37731967 P2860 Q37731967-616FAED9-BD0F-45E9-A65F-F2EB84B6B0D6 @default.
- Q37731967 P2860 Q37731967-6C0BA43C-1612-42A6-8D93-D5578F9530E4 @default.
- Q37731967 P2860 Q37731967-6FE95E3A-27D7-4C50-BBBE-BD8202EA3BF9 @default.
- Q37731967 P2860 Q37731967-74689FE7-BA1F-4257-BCFE-832B8FDF4C93 @default.
- Q37731967 P2860 Q37731967-7A28C4C2-4288-427D-8330-B4E584564E8F @default.
- Q37731967 P2860 Q37731967-82EDF60D-05CD-4687-B544-ED5A05AA03F7 @default.
- Q37731967 P2860 Q37731967-8919C581-F816-4018-89D4-B2BCE5E3D67C @default.
- Q37731967 P2860 Q37731967-9145828D-4112-4325-9B86-5A5CDDDE7121 @default.
- Q37731967 P2860 Q37731967-A18659D0-DC5A-4651-B6C1-28C36E388422 @default.
- Q37731967 P2860 Q37731967-B6DE341A-4BA9-44DF-9F34-89AEEE2CC448 @default.
- Q37731967 P2860 Q37731967-CA9E67A2-C34A-4019-9CFC-58A3117CAC5C @default.
- Q37731967 P2860 Q37731967-D2A0AA40-0326-4DE7-B3AF-DE10D9C95C5C @default.
- Q37731967 P2860 Q37731967-D5CAA01D-0D81-46DF-95B7-A7BAC4E72EA4 @default.
- Q37731967 P2860 Q37731967-DC4F0E84-233C-41FB-86B7-CC16FF33F951 @default.
- Q37731967 P2860 Q37731967-E124E325-CD35-4C95-A051-A1840717B6B3 @default.
- Q37731967 P2860 Q37731967-ED1A7AF1-D5DB-4F71-B5B7-8BB533D0BE71 @default.
- Q37731967 P2860 Q37731967-F79C702E-495F-452A-83C9-3825059F86BD @default.
- Q37731967 P2860 Q37731967-F9F0E1F3-635F-4BE6-9558-A883F367664D @default.
- Q37731967 P304 Q37731967-B837D024-0A28-4ABD-A859-EA86BF263602 @default.
- Q37731967 P31 Q37731967-562B1827-13A0-4AFA-9FCC-445E324F25CC @default.
- Q37731967 P356 Q37731967-4EDBB95E-E59A-4ED1-A728-B9B0EB36B3E0 @default.
- Q37731967 P407 Q37731967-8B5107EA-F47D-416F-819C-EDC6FA5FD888 @default.
- Q37731967 P433 Q37731967-1CCEC615-2CDD-4F57-BE42-3B4BAEC81884 @default.
- Q37731967 P478 Q37731967-DE2AA5E2-5ED7-4366-BD03-3E4FFA2894C7 @default.
- Q37731967 P577 Q37731967-3BDFEB07-0E85-490D-970A-34F8782A9798 @default.
- Q37731967 P698 Q37731967-C29FF137-CAF9-4775-AFF0-71570A6EA5CD @default.
- Q37731967 P921 Q37731967-64ACA3FD-251E-4AF7-8E58-37A4194E246E @default.
- Q37731967 P921 Q37731967-7CA72FAE-CAAF-4852-9AC5-9F25BDADB675 @default.
- Q37731967 P932 Q37731967-8E5C0956-251B-43BD-9E4D-4127C9B10B99 @default.
- Q37731967 P356 MCO.2017.1187 @default.
- Q37731967 P698 28413657 @default.
- Q37731967 P1433 Q27725125 @default.
- Q37731967 P1476 "A feasibility study of bevacizumab and vinorelbine in patients with previously treated advanced non-squamous non-small-cell lung cancer" @default.
- Q37731967 P2093 "Hiroshi Kobayashi" @default.
- Q37731967 P2093 "Kazutoshi Isobe" @default.
- Q37731967 P2093 "Kyohei Kaburaki" @default.
- Q37731967 P2093 "Sakae Homma" @default.
- Q37731967 P2093 "Takahiro Yoshizawa" @default.
- Q37731967 P2093 "Yujiro Takai" @default.
- Q37731967 P2860 Q27860904 @default.
- Q37731967 P2860 Q28278736 @default.
- Q37731967 P2860 Q33187344 @default.
- Q37731967 P2860 Q33337182 @default.
- Q37731967 P2860 Q33408836 @default.
- Q37731967 P2860 Q34050239 @default.
- Q37731967 P2860 Q34935734 @default.
- Q37731967 P2860 Q36778505 @default.
- Q37731967 P2860 Q36811479 @default.
- Q37731967 P2860 Q38245038 @default.
- Q37731967 P2860 Q38940816 @default.
- Q37731967 P2860 Q40112553 @default.
- Q37731967 P2860 Q41005730 @default.
- Q37731967 P2860 Q42632045 @default.
- Q37731967 P2860 Q43790301 @default.
- Q37731967 P2860 Q44346771 @default.
- Q37731967 P2860 Q46972019 @default.
- Q37731967 P2860 Q48053447 @default.
- Q37731967 P2860 Q50773969 @default.